Among the multitude of products, find crop tops, leggings, select outerwear and accessories all on sale.
The Rays' postseason star has been detained in Mexico over an alleged family dispute.
American Eagle Outfitters, Inc. (NYSE: AEO) today reported operating income of $96 million for the 13 weeks ended October 31, 2020, compared to $103 million for the 13 weeks ended November 2, 2019. Adjusted operating income of $103 million this year excluded $7 million of expenses primarily related to COVID-19 protocols.
NetApp (NASDAQ: NTAP), a global cloud-led, data centric software company, today announced the Company will participate virtually in fireside chats at the following conferences:
Michelle Clatterbuck, chief financial officer of Intuit (Nasdaq: INTU) will present at the Credit Suisse Technology Virtual Conference on Dec. 1.
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its underwritten public offering of 2,875,000 shares of its common stock, including 375,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $39.00 per share. The net proceeds from the offering were approximately $105.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.
Corrections and clarifications. Moderna Covid-19 vaccine | Longmeadow
The Cottonseed Market will grow by USD 2.28 bn during 2020-2024
Sasan Goodarzi, chief executive officer of Intuit (Nasdaq: INTU) will present at the 43rd Nasdaq Investor Virtual Conference on Dec. 1.
Daix (France), November 24, 2020 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. During the conference, Inventiva will engage in 1x1 investor meetings as well as in a fire-side chat with an analyst from Piper Sandler. The event details are as follows: Format: Analyst fireside chatSpeakers: Frédéric Cren, Chairman, CEO and cofounder of Inventiva, and Pierre Broqua, Chief Scientific Officer and cofounder of InventivaReplay link (available as of now): https://pipersandler.zoom.us/rec/play/jN7bcT_RWHs6wFUWvRTd2cOENx4J6KOawInzHhY6Bd8BZ-WLH1hvHPJPy7ct5Ns737Qr6dp2ZGY5yvxG.TT4iwmadZzEQ_McZ The link to the event will also be available on Inventiva’s website in the “Investors – Investor Presentations” section. About Inventiva Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Leveraging its expertise and experience in the domain of compounds targeting nuclear receptors, transcription factors and epigenetic modulation, Inventiva is currently advancing two clinical candidates, as well as a deep pipeline of earlier stage programs. Lanifibranor, its lead product candidate, is being developed for the treatment of patients with NASH, a common and progressive chronic liver disease for which there are currently no approved therapies. Inventiva recently announced positive topline data from its Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH and obtained Breakthrough Therapy and Fast Track designation for lanifibranor in the treatment of NASH. Inventiva is also developing odiparcil, a second clinical stage asset, for the treatment of patients with subtypes of MPS, a group of rare genetic disorders. Inventiva announced positive topline data from its Phase IIa clinical trial evaluating odiparcil for the treatment of adult MPS VI patients at the end of 2019 and received FDA Fast Track designation in MPS VI for odiparcil in October 2020. In parallel, Inventiva is in the process of selecting an oncology development candidate for its Hippo signalling pathway program. Furthermore, the Company has established a strategic collaboration with AbbVie in the area of autoimmune diseases. AbbVie has started the clinical development of ABBV‑157, a drug candidate for the treatment of moderate to severe psoriasis resulting from its collaboration with Inventiva. This collaboration enables Inventiva to receive milestone payments upon the achievement of pre-clinical, clinical, regulatory and commercial milestones, in addition to royalties on any approved products resulting from the collaboration. The Company has a scientific team of approximately 70 people with deep expertise in the fields of biology, medicinal and computational chemistry, pharmacokinetics and pharmacology, as well as in clinical development. It also owns an extensive library of approximately 240,000 pharmacologically relevant molecules, approximately 60% of which are proprietary, as well as a wholly‑owned research and development facility. Inventiva is a public company listed on compartment C of the regulated market of Euronext Paris (ticker: IVA - ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). www.inventivapharma.com Contacts Inventiva Frédéric Cren Chairman & CEO firstname.lastname@example.org +33 3 80 44 75 00 Brunswick Group Yannick Tetzlaff / Tristan Roquet Montegon / Aude Lepreux Media relations email@example.com +33 1 53 96 83 83 Westwicke, an ICR Company Patricia L. Bank Investor relations firstname.lastname@example.org +1 415 513 1284 Attachment Inventiva - PR - Piper Sandler 32nd Annual Virtual Healthcare Conference - EN - 24 11 20
Black Friday GizmoWatch deals for 2020 are finally here, find all the best Black Friday Verizon Gizmo Watch smartwatch savings right here
The Elevated Spirits Company is pleased to announce that Cierto Tequila was honored with an incredible six (6) medals at the 2020 Melbourne International Spirits Competition (MISC). The MISC honored Cierto with two Gold medals, one Silver medal, two Bronze medals and named Cierto Tequila the "Distiller of the Year." With these six new medals and awards, Cierto Tequila has now won two hundred and thirty-one (231) international medals and awards - far surpassing all other tequila brands. Cierto Tequila is an authentic, 100% natural "true" tequila made exclusively from healthy, mature highland agave in Jalisco, Mexico. Due to its character, complexity and incredibly smooth taste, tequila experts around the globe have called Cierto the "World’s Finest Tequila."
Giroud came off the bench to send the Blues into the second round of the Champions League.
"We were good friends for a long time. Obviously, that has changed."
The Dow has set a new record, as investors look beyond the COVID-19 spike to a vaccine.
Hours after tweeting that he would release transition funds after all, the annual tradition became a weird concession speech by proxy
CTRL is a biokinetic sleeve that gives personalized feedback in order to help users improve upon their golf swing.
Doctors warn that testing negative for coronavirus is not a ‘free pass’
Advancements in several key data and power delivery protocol standards bring a new level of convenience and capability to new car buyers.
(Bloomberg) -- India’s mass transit systems, unreliable even before the coronavirus pandemic, were shut off completely when the country locked down. As a result, Indians rushed to find alternative transportation, and that often meant used cars.A major beneficiary was Cars24 Services Pvt., an online marketplace for used cars based in Gurgaon, India. The company’s valuation jumped to more than $1 billion after a new round of funding, Cars24 plans to announce Tuesday. DST Global, an investment firm overseen by Russia-born billionaire Yuri Milner, led the $200 million deal.The investment doubles the total funds raised by Cars24 since the business was established five years ago. The chief executive officer and co-founder, Vikram Chopra, was an investment analyst early in his career at Sequoia Capital, one of the world’s most prominent venture capital firms and now a Cars24 investor. Chopra started Cars24 after having a hard time selling his Hyundai Accent before a temporary move to the U.S., he said. Daunted by the situation, he ended up giving his car to a friend instead, he said.By the middle of this year, Cars24 saw sales rise 20% from pre-lockdown levels. That followed some weeks in the spring when the site generated no revenue whatsoever. At first, Chopra thought the numbers reflected pent-up demand that would be short-lived but said sustained high levels of traffic to the site suggest otherwise. Cars24, which takes a cut of each transaction, is on track to generate estimated gross annual revenue of $600 million, Chopra said. “Our awareness among consumers has shot up dramatically,” he said.India’s pre-owned vehicle market is fragmented and dominated by mom-and-pop operations. Online retailers like Cars24, Droom and OLX, along with the automakers themselves, offer a more consistent buying experience, simplified paperwork and access to lenders. India lacks a system to establish fair values for used cars like Kelley Blue Book, making the process more complicated and opaque.As the pandemic drags on, trains and buses in Bangalore, Delhi and Mumbai have resumed service, but fear of contracting the virus is keeping many commuters away. Coronavirus cases in India surpassed 9 million; infections are soaring; and multiple cities are contemplating further lockdowns.For Cars24, the new investor brings, as its name implies, a global expertise. DST Global is based in Hong Kong and has backed a varied list of companies over the years, including Facebook Inc. and WhatsApp in the U.S. and Alibaba Group Holding Ltd. in China.In India, DST invested in the online shopping company Flipkart, which sold an 80% stake to Walmart Inc. two years ago in a transaction that valued the startup at about $20 billion, and built up the firm’s awareness of the challenges around online marketplaces in India. This year, DST invested in the country’s prominent education-tech startup, Byju’s. What made Cars24 stand out was its ability to handle so many steps, including remote inspections of vehicles, said Rahul Mehta, a Dubai-based managing partner at DST. “You have to be deep into operations,” he said. “These guys have done well.”(Corrects the nature of DST’s role in the deal in the second paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.